Blueprint Medicines Corp

General ticker "BPMC" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $6.0B

Blueprint Medicines Corp follows the US Stock Market performance with the rate: 34.8%.

Estimated limits based on current volatility of 2.5%: low 88.03$, high 92.60$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [52.00$, 105.97$]
  • 2024-12-30 to 2025-12-30 estimated range: [44.76$, 92.81$]

Financial Metrics affecting the BPMC estimates:

  • Negative: Non-GAAP EPS, $ of -8.36 <= 0.10
  • Negative: Operating profit margin, % of -66.10 <= 1.03
  • Negative: Operating cash flow per share per price, % of -8.35 <= 2.35
  • Negative: negative Net income

Similar symbols

Short-term BPMC quotes

Long-term BPMC plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $180.98MM $189.27MM $249.38MM
Operating Expenses $822.06MM $741.55MM $735.66MM
Operating Income $-641.08MM $-552.28MM $-486.28MM
Non-Operating Income $0.00MM $0.00MM $-19.74MM
Interest Expense $0.00MM $16.77MM $0.00MM
R&D Expense $601.03MM $477.42MM $427.72MM
Income(Loss) $-641.08MM $-552.28MM $-506.02MM
Taxes $3.00MM $5.24MM $0.97MM
Profit(Loss) $-644.09MM $-557.52MM $-506.98MM
Stockholders Equity $970.74MM $514.68MM $130.61MM
Inventory $21.82MM $29.70MM $21.22MM
Assets $1,252.22MM $1,349.90MM $1,049.25MM
Operating Cash Flow $-298.65MM $-502.28MM $-436.85MM
Capital expenditure $261.24MM $8.92MM $16.06MM
Investing Cash Flow $-225.86MM $-149.54MM $274.04MM
Financing Cash Flow $50.72MM $561.81MM $119.22MM
Earnings Per Share* $-11.01 $-9.35 $-8.37

* EPS are Split Adjusted, recent splits may be reflected with a delay.